(Q38918609)

7 September 2017

1 reference

title

Molecular mechanisms involved in dendritic cell dysfunction in cancer (English)

1 reference

7 September 2017

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27491428%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Michael Tang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27491428%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Jun Diao

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27491428%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

5 August 2016

1 reference

Cellular and Molecular Life Sciences

7 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27491428%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27491428%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27491428%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

761-776

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27491428%20AND%20SRC:MED&resulttype=core&format=json

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Taking dendritic cells into medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Tolerogenic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Dendritic cells in a mature age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Pathogen recognition and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Dendritic cells maximize the memory CD8 T cell response to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Programmed cell death of dendritic cells in immune regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Regulation of the trafficking of tumour-infiltrating dendritic cells by chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Altered maturation of peripheral blood dendritic cells in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Tumour escape from immune surveillance through dendritic cell inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Lipid accumulation and dendritic cell dysfunction in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Monocytes and macrophages: developmental pathways and tissue homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Characterization of distinct conventional and plasmacytoid dendritic cell-committed precursors in murine bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

In situ replication of immediate dendritic cell (DC) precursors contributes to conventional DC homeostasis in lymphoid tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Critical roles of interferon regulatory factor 4 in CD11bhighCD8alpha- dendritic cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

The origin and development of nonlymphoid tissue CD103+ DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Monocytes give rise to mucosal, but not splenic, conventional dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Origin of the lamina propria dendritic cell network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Origin and development of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Conditional expression of murine Flt3 ligand leads to expansion of multiple dendritic cell subsets in peripheral blood and tissues of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Antigen transmission by replicating antigen-bearing dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Malaria infection changes the ability of splenic dendritic cell populations to stimulate antigen-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Deciphering the transcriptional network of the dendritic cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Transcriptional profiling identifies Id2 function in dendritic cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

NFIL3/E4BP4 is a key transcription factor for CD8α⁺ dendritic cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

IRF8 mutations and human dendritic-cell immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Adoptive immunotherapy for cancer: harnessing the T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Mutanome directed cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

CD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

The three Es of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Expression of tumour-specific antigens underlies cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Altered macrophage differentiation and immune dysfunction in tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Regulatory T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Dendritic cells in tissues: in situ stimulation of immunity and immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Random migration precedes stable target cell interactions of tumor-infiltrating T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

The emerging understanding of myeloid cells as partners and targets in tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Deciphering the message broadcast by tumor-infiltrating dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Recruitment and differentiation of conventional dendritic cell precursors in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Ovarian cancer progression is controlled by phenotypic changes in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Immunostimulatory conventional dendritic cells evolve into regulatory macrophage-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

The cell biology of cross-presentation and the role of dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Processing and presentation of tumor antigens and vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Capitalizing on the immunogenicity of dying tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Specific immunogenicity of heat shock protein gp96 derives from chaperoned antigenic peptides and not from contaminating proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Hsp90-mediated cytosolic refolding of exogenous proteins internalized by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Cross-presentation by intercellular peptide transfer through gap junctions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Dendritic cells acquire antigens from live cells for cross-presentation to CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Cancer immunotherapy by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Defective MHC class II presentation by dendritic cells limits CD4 T cell help for antitumor CD8 T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Visualization of immediate immune responses to pioneer metastatic cells in the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Dendritic cell subsets require cis-activation for cytotoxic CD8 T-cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Mini‐review: Regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross‐priming and direct priming?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Tumor-infiltrating dendritic cells in cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Accumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

PD-1 Blunts the Function of Ovarian Tumor-Infiltrating Dendritic Cells by Inactivating NF-κB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Immune suppressive mechanisms in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

IDO activates regulatory T cells and blocks their conversion into Th17-like T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

IDO-expressing regulatory dendritic cells in cancer and chronic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Mechanisms and functional significance of tumour-induced dendritic-cell defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

A Death Notice for In-Vitro-Generated GM-CSF Dendritic Cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c(+)MHCII(+) Macrophages and Dendritic Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

IL-6 in autoimmune disease and chronic inflammatory proliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

A cytokine-mediated link between innate immunity, inflammation, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

IL-6 as a keystone cytokine in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Interleukin-6 and its receptor in cancer: implications for translational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

MicroRNA expression, survival, and response to interferon in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

IL-6 switches the differentiation of monocytes from dendritic cells to macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Increased and long-term generation of dendritic cells with reduced function from IL-6-deficient bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Imbalanced gp130-dependent signaling in macrophages alters macrophage colony-stimulating factor responsiveness via regulation of c-fms expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Strategies for use of IL-10 or its antagonists in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Ammonium trichloro(dioxoethylene-o,o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

IL-12 Induction by a Th1-Inducing Adjuvant In Vivo: Dendritic Cell Subsets and Regulation by IL-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

VEGF-targeted therapy: mechanisms of anti-tumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Revisiting STAT3 signalling in cancer: new and unexpected biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

The role of IL-6 and STAT3 in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Toll-like Receptor 2 Activation Promotes Tumor Dendritic Cell Dysfunction by Regulating IL-6 and IL-10 Receptor Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Immunoregulation of dendritic cells by the receptor T cell Ig and mucin protein-3 via Bruton's tyrosine kinase and c-Src

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Developing dendritic cells become 'lacy' cells packed with fat and glycogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Radiation-driven lipid accumulation and dendritic cell dysfunction in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Oxidized lipids block antigen cross-presentation by dendritic cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Targeting the unfolded protein response in disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Proteasome inhibitors disrupt the unfolded protein response in myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

The transcription factor XBP-1 is essential for the development and survival of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

The unfolded-protein-response sensor IRE-1α regulates the function of CD8α+ dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Role of tumor-associated gangliosides in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

The role of gangliosides in neurodevelopment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Versican expression is associated with tumor-infiltrating CD8-positive T cells and infiltration depth in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Versican is differentially expressed in human melanoma and may play a role in tumor development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Blocking TLR2 activity attenuates pulmonary metastases of tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

The microbiome and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Immunogenic cell death in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Subversion of anticancer immunosurveillance by radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Dendritic-cell-based therapeutic cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Dendritic Cell-Induced Memory T Cell Activation in Nonlymphoid Tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Targeting Tumor Antigens to Secreted Membrane Vesicles In vivo Induces Efficient Antitumor Immune Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

NOX2 Controls Phagosomal pH to Regulate Antigen Processing during Crosspresentation by Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

Activation of Dendritic Cells That Cross-Present Tumor-Derived Antigen Licenses CD8+ CTL to Cause Tumor Eradication

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00018-016-2317-8

21 January 2018

12 December 2020

Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery

1 reference

12 December 2020

Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function

1 reference

12 December 2020

Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck

1 reference

12 December 2020

Tumors suppress in situ proliferation of cytotoxic T cells by promoting differentiation of Gr-1(+) conventional dendritic cells through IL-6

1 reference

12 December 2020

Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function

1 reference

12 December 2020

Cross-presentation of antigens from apoptotic tumor cells by liver sinusoidal endothelial cells leads to tumor-specific CD8+ T cell tolerance

1 reference

12 December 2020

RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells

1 reference

12 December 2020

Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells

1 reference

12 December 2020

Receptor clearance obscures the magnitude of granulocyte-macrophage colony-stimulating factor responses in mice to endotoxin or local infections

1 reference

12 December 2020

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

1 reference

12 December 2020

Clinical significance of defective dendritic cell differentiation in cancer

1 reference

12 December 2020

IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells

1 reference

12 December 2020

Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence

1 reference

12 December 2020

In vivo analysis of dendritic cell development and homeostasis

1 reference

12 December 2020

In vivo generation of human dendritic cell subsets by Flt3 ligand

1 reference

12 December 2020

Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy

1 reference

12 December 2020

CD8alpha+ DC are not the sole subset cross-presenting cell-associated tumor antigens from a solid tumor

1 reference

12 December 2020

Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer.

1 reference

12 December 2020

Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells.

1 reference

12 December 2020

Dendritic cell apoptosis in the maintenance of immune tolerance

1 reference

12 December 2020

IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity

1 reference

12 December 2020

Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression

1 reference

12 December 2020

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

12 December 2020

Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses

1 reference

12 December 2020

Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells

1 reference

12 December 2020

1 reference

12 December 2020

Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells

1 reference

12 December 2020

Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo

1 reference

12 December 2020

10.1007/S00018-016-2317-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27491428%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference